Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The plasma membrane electron transport system (PMET) is a complex network of cytosolic and membrane-associated oxidoreductase enzymes embedded in the plasma membrane that transfer electrons from intracellular donors (primarily NADH and NADPH) to extracellular acceptors. This system helps maintain cellular redox homeostasis, supports metabolic processes (such as regulation of glycolytic flux in pancreatic β-cells), and provides defense against oxidative stress. Its composition varies across cell types and may involve enzymes such as NADH-cytochrome B5 oxidoreductase, NAD(P)H-quinone oxidoreductase 1 (NQO1), and NADPH oxidases (e.g., NOX2). While it plays important physiological roles, "plasma membrane electron transport system" is not a single protein or druggable target but a descriptor for a distributed, functionally related assembly of redox enzymes.
Inhibitors of PMET components might block cellular redox cycling, reduce extracellular electron transfer, or alter reactive oxygen species (ROS) production.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasma membrane electron transport system (PMET).